Skip to main content
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
11.62
+0.72 (6.61%)
Nov 13, 2026, 4:00 PM EST - Market closed

Fennec Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
66.3744.6447.5421.251.54-
Revenue Growth
71.09%-6.09%123.69%1284.50%--
Gross Profit
62.4740.8844.3519.991.45-
Operating Income
3.72-6.282.57-12.77-22.59-17.22
Net Income
2.03-9.74-0.44-16.05-23.71-17.35
Earnings Per Share
0.06-0.34-0.02-0.60-0.90-0.67
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
48.6836.7926.6313.2723.7721.1
Total Debt
--19.3430.9524.94.99
Net Cash (Debt)
48.6836.797.29-17.68-1.1316.11
Net Cash Growth
1794.32%404.36%----46.90%
Net Cash Per Share
1.381.290.27-0.67-0.040.62

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3.15-12.4726.98-17.14-18.06-14.22
Free Cash Flow
3.15-12.4726.98-17.14-18.06-14.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
94.13%91.57%93.30%94.08%94.40%-
Operating Margin
5.60%-14.07%5.40%-60.09%-1471.60%-
Pretax Margin
3.78%-21.58%-0.15%-75.50%-1544.89%-
Profit Margin
3.05%-21.82%-0.92%-75.50%-1544.89%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
14.0315.8837.3690.856.326.32
PS Ratio
6.185.893.6514.25164.24-